BriaCell Announces Completion of 15:1 Share Consolidation
BriaCell Announces Completion of 15:1 Share Consolidation GlobeNewswire January 27, 2025 PHILADELPHIA and VANCOUVER, British Columbia, Jan. 27, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company“), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care announces that on January 24, 2025 (the “Effective Date“), […]